Table 5.

Pathologic findings in control and SS mice



Genotype


Control; n = 16
Sickle; n = 15
P
Spleen    
   Gross infarcts, % positive   0   27   .04  
   Micros infarct, % positive   0   40   .007  
   Diameter, mm   2.2   5.7   < .001  
   Iron, all ages   1.9   4.4   < .001  
      2 y or younger   0   2.7   NA  
      Older than 2 y   2.6   5.9   NA  
   Hematopoiesis   0.3; n = 6   5.9   < .001  
   Vascular ectasia, all ages   0.8   4.4   < .001  
      2 y or younger   0.5   3.7   NA  
      Older than 2 y   0.9   5.0   NA  
Liver    
   Mononuclear, % positive   6   67   < .001  
   Gross infarcts, % positive   0   27   .04  
   Micros infarcts, % positive   0; n = 6   100   < .001  
   Iron, % positive   0   100   < .001  
   Iron, mean of positive scores   NA   4.1   NA  
   Calcification, % positive   0   60   < .001  
   Perivenous pallor, % positive   6   20   NS  
Kidney    
   Cortical width, μm   25.8   42.1   < .001  
   Gross infarcts, % positive   0   20   .10  
   Micros infarcts, % positive   0   67   < .001  
   Iron, % positive*  6   93   < .001  
   Iron, mean of positive scores   1.0   4.1   NA  
   Glomerular size, U   2.7   4.5   < .001  
   Arterial wall, μm   1.7   2.1   NS  
   Mononuclear infiltrates, % positive   0   40   .007  
Lungs    
   Lymphs, % positive   12.5   20   NS  
   Iron, all ages, % positive   0   80   < .001  
      2 y or younger   0   57   NA  
      Older than 2 y   0   100   NA  
   Iron, all ages, mean of positive scores   NA   1.75   NA  
   Capillary congestion, % positive   0; n = 6   93   .001  
   Pulmonary artery wall, μm   1.8   2.7   .002  
   Hemorrhage, % positive   0; n = 6   60   .02  
Heart    
   Micros infarcts, % positive   0   33   .02  
   Iron, % positive   6   33   .08  
   Iron, mean of positive scores   1.0   1.2   NA  
   Blood vessel diameter, μm  3.7; n = 15   4.9   .02  
   Blood vessel wall thickness, % greater than 1 μm   12.5   80   < .001  
Brain and eye    
   Pyknotic Purkinje cells, %   0   93   < .001  
   Retinal degeneration, %   0   100   < .001  
Bone marrow    
   Iron, %   17   67   .02  
   Iron, mean of positive scores   1.5   1.3   NA  
   Cellularity score   5.1   4.2   < .001  
   Erythroid hyperplasia score
 
0.88
 
4.8
 
< .001
 


Genotype


Control; n = 16
Sickle; n = 15
P
Spleen    
   Gross infarcts, % positive   0   27   .04  
   Micros infarct, % positive   0   40   .007  
   Diameter, mm   2.2   5.7   < .001  
   Iron, all ages   1.9   4.4   < .001  
      2 y or younger   0   2.7   NA  
      Older than 2 y   2.6   5.9   NA  
   Hematopoiesis   0.3; n = 6   5.9   < .001  
   Vascular ectasia, all ages   0.8   4.4   < .001  
      2 y or younger   0.5   3.7   NA  
      Older than 2 y   0.9   5.0   NA  
Liver    
   Mononuclear, % positive   6   67   < .001  
   Gross infarcts, % positive   0   27   .04  
   Micros infarcts, % positive   0; n = 6   100   < .001  
   Iron, % positive   0   100   < .001  
   Iron, mean of positive scores   NA   4.1   NA  
   Calcification, % positive   0   60   < .001  
   Perivenous pallor, % positive   6   20   NS  
Kidney    
   Cortical width, μm   25.8   42.1   < .001  
   Gross infarcts, % positive   0   20   .10  
   Micros infarcts, % positive   0   67   < .001  
   Iron, % positive*  6   93   < .001  
   Iron, mean of positive scores   1.0   4.1   NA  
   Glomerular size, U   2.7   4.5   < .001  
   Arterial wall, μm   1.7   2.1   NS  
   Mononuclear infiltrates, % positive   0   40   .007  
Lungs    
   Lymphs, % positive   12.5   20   NS  
   Iron, all ages, % positive   0   80   < .001  
      2 y or younger   0   57   NA  
      Older than 2 y   0   100   NA  
   Iron, all ages, mean of positive scores   NA   1.75   NA  
   Capillary congestion, % positive   0; n = 6   93   .001  
   Pulmonary artery wall, μm   1.8   2.7   .002  
   Hemorrhage, % positive   0; n = 6   60   .02  
Heart    
   Micros infarcts, % positive   0   33   .02  
   Iron, % positive   6   33   .08  
   Iron, mean of positive scores   1.0   1.2   NA  
   Blood vessel diameter, μm  3.7; n = 15   4.9   .02  
   Blood vessel wall thickness, % greater than 1 μm   12.5   80   < .001  
Brain and eye    
   Pyknotic Purkinje cells, %   0   93   < .001  
   Retinal degeneration, %   0   100   < .001  
Bone marrow    
   Iron, %   17   67   .02  
   Iron, mean of positive scores   1.5   1.3   NA  
   Cellularity score   5.1   4.2   < .001  
   Erythroid hyperplasia score
 
0.88
 
4.8
 
< .001
 

Measurements are mean values of all grading scores unless otherwise designated as percentage of animals with positive scores and corresponding mean of the positive scores.

NA indicates not applicable; NS, not significant.

*

Among SS animals, iron scores in the kidney increased by .85 for each month of age (P < .001)

Among SS animals, sex and age were independent factors associated with cardiac vascular ectasia (coefficient = 1.5 for male sex [P = .03] and .44 for each month of age [P = .03])

or Create an Account

Close Modal
Close Modal